Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Intangibles (2022 - 2024)

TriSalus Life Sciences has reported Intangibles over the past 3 years, most recently at $1.1 million for Q2 2024.

  • For Q2 2024, Intangibles changed N/A year-over-year to $1.1 million; the TTM value through Jun 2024 reached $1.1 million, changed N/A, while the annual FY2023 figure was $1.1 million, 40.52% up from the prior year.
  • Intangibles for Q2 2024 was $1.1 million at TriSalus Life Sciences, roughly flat from $1.1 million in the prior quarter.
  • Over five years, Intangibles peaked at $1.1 million in Q4 2023 and troughed at $802000.0 in Q4 2022.
  • A 3-year average of $1.0 million and a median of $1.1 million in 2024 define the central range for Intangibles.
  • On a YoY basis, Intangibles climbed as much as 40.52% in 2023 and fell as far as 40.52% in 2023.
  • Year by year, Intangibles stood at $802000.0 in 2022, then surged by 40.52% to $1.1 million in 2023, then fell by 1.24% to $1.1 million in 2024.
  • Business Quant data shows Intangibles for TLSI at $1.1 million in Q2 2024, $1.1 million in Q1 2024, and $1.1 million in Q4 2023.